In vitro and in vivo evaluation of 64Cu-TETA-Tyr3-octreotate. A new somatostatin analog with improved target tissue uptake

Nuclear Medicine and Biology

Volumn 26, Issue 3, 1999, Pages 267-273

  Lewis, Jason S ^a   Srinivasan, Ananth ^b   Schmidt, Michelle A ^b   Anderson, Carolyn J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MALLINCKRODT PHARMACEUTICALS   (United States)

Author keywords

Copper radionuclides; Octreotide; PET; Somatostatin; Tyr3 octreotate

Indexed keywords

COPPER 64; CYCLAM DERIVATIVE; OCTREOTIDE; SOMATOSTATIN DERIVATIVE;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DRUG CLEARANCE; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; DRUG UPTAKE; ISOTOPE LABELING; MALE; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RAT; RECEPTOR BINDING;

ANIMALS; BONE AND BONES; COPPER RADIOISOTOPES; FEMALE; MALE; MICE; MICE, SCID; ORGANOMETALLIC COMPOUNDS; PANCREATIC NEOPLASMS; PAPIO; RADIOPHARMACEUTICALS; RATS; RATS, INBRED LEW; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033119067     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(98)00105-X     Document Type: Article

References (33)

1. Anderson C.J., Jones L.A., Bass L.A., Sherman E.L.C., McCarthy D.W., Cutler P.D., Lanahan M.V., Cristel M.E., Lewis J.S., Schwarz S.W. Radiotherapy, toxicity and dosimetry of copper-64-TETA-octreotide in tumor bearing rats. J. Nucl. Med. 39:1998;1944-1951.
2. Anderson C.J., Pajeau T.S., Edwards W.B., Sherman E.L.C., Rogers B.E., Welch M.J. In vitro and in vivo evaluation of copper-64-octreotide conjugates. J. Nucl. Med. 36:1995;2315-2325.
3. 111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors Synthesis, radiolabeling and in vitro validation . Life Sci. 49:1991;1583-1591.
4. Bakker W.H., Krenning E.P., Breeman W.A., Kooji P.P.M., Reubi J.C., Koper J.W., De Jong M., Lameris J.S., Visser T.J., Lamberts S.W.J. In vivo use of radioiodinated somatostatin analogue Dynamics, metabolism and binding to somatostatin receptor-positive tumors in man . J. Nucl. Med. 32:1991;1184-1189.
5. Blower P.J., Lewis J.S., Zweit J. Copper radionuclides and radiopharmaceuticals in nuclear medicine. Nucl. Med. Biol. 23:1996;957-980.
6. 123I-Tyr3]octreotide . Eur. J. Nucl. Med. 20:1993;1089-1094.
7. Bruns C., Dietl M.M., Palacios J.M., Pless J. Identification and characterization of somatostatin receptors in neonatal rat long bones. Biochem. J. 265:1990;39-44.
8. Bruns C., Raulf F., Hoyer D., Schloos J., Lubbert H., Weckbecker G. Binding properties of somatostatin receptor subtypes. Metabolism. 45:1996;17-20.
9. Dehdashti F., Anderson C.J., Trash D.D., Bass L.A., Schwarz S.W., Cutler P.D., McCarthy D.W., Lanahan M.V. Initial results with PET imaging using Cu-64-labeled TETA-octreotide in patients with carcinoid tumor. J. Nucl. Med. 38:1997;103P.
10. 3]octreotide as carriers for octreotide receptor-targeted scintigraphy and radionuclide therapy. Int. J. Cancer. 75:1998;406-411.
11. 111In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy. Cancer Res. 58:1998;437-441.
12. 161Tb-DTPA-octreotide, a somatostatin analogue with potential for intraoperative scanning and radiotherapy. Eur. J. Nucl. Med. 22:1995;608-616.
13. Edwards W.B., Fields C.G., Anderson C.J., Pajeau T.S., Welch M.J., Fields G.B. Generally applicable, convenient solid phase synthesis and receptor affinities of octreotide analogs. J. Med. Chem. 37:1994;3749-3757.
14. Lamberts S.W.J., Bakker W.H., Reubi J.C., Krenning E.P. Somatostatin receptor imaging In vivo localization of tumors with a radiolabeled somatostatin analog . J. Steroid Biochem. Mol. Biol. 37:1990;1079-1082.
15. 3-octreotate in a somatostatin receptor positive tumor bearing rat model. J. Nucl. Med. 39:1998;104P.
16. Longnecker D.S., Lilja H.S., French J., Kuhlmann E., Noll W. Transplantation of azaserine-induced carcinomas of pancreas in rats. Cancer Lett. 7:1979;197-202.
17. Mackie E.J., Trechsel U., Bruns C. Somatostatin receptors are restricted to a subpopulation of osteoblast-like cells during endochondral bone formation. Development. 110:1990;1233-1239.
18. Maina T., Stolz B., Albert R., Bruns C., Koch P., Mäcke H. Synthesis, radiochemistry and biological evaluation of a new somatostatin analogue (SDZ 219-387) labelled with technetium-99m. Eur. J. Nucl. Med. 21:1994;437-444.
19. 64Cu using a biomedical cyclotron. Nucl. Med. Biol. 24:1997;35-43.
20. Mishra A.K., Draillard K., Faivrechauvet A., Gestin J.F., Curtet C., Chatal J.F. A convenient, novel approach for the synthesis of polyaza macrocyclic bifunctional chelating agents. Tetrahedron Lett. 37:1996;7515-7518.
21. Otte A., Mueller-Brand J., Goetze M., Hermann R., Nitzsche H.R., Mäcke H.R. Yttrium-90-DOTA-Octreotide treatment of somatostatin receptor positive tumors. J. Nucl. Med. 39:1998;70P.
22. Reubi J.C., Heitz P.U., Landolt A.M. Visualization of somatostatin receptors and correlation with immunoreactive GH and PRL in human pituitary adenomas Evidence for different tumor subclasses . J. Clin. Endocrinol. Metab. 65:1987;65-73.
23. Reubi J.C., Kvols L.K., Krenning E.P., Lamberts S.W.J. Distribution of somatostatin receptors in normal and tumor tissue. Metabolism. 39:1990;78-81.
24. Reubi J.C., Kvols L.K., Waser B., Nagorney D., Heitz P.U., Charboneau J.W., Reading C.C., Moertel C. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Cancer Res. 50:1990;5969-5977.
25. Reubi J.C., Maurer R., Klijn J.G.M., Stefanko S.Z., Foekens J.A., Blaauw G., Blankenstein M.A., Lamberts S.W.J. High incidence of somatostatin receptors in human meningiomas biochemical characterization . J. Clin. Endocrinol. Metab. 63:1986;433-438.
26. Reubi J.C., Waser B., Sheppard M., Macaulay V. Somatostatin receptors are present in small-cell by not in non-small-cell primary lung carcinomas Relationship to EGF receptors . Int. J. Cancer. 45:1990;269-274.
27. Schloos J., Raulf F., Hoyer G., Engel G., Bruns C. Identification and characterization of somatostatin receptors expressed in rat lung tissue. Br. J. Pharm. 114:(suppl):1995;49P.
28. Smith-Jones P.M., Stolz B., Albert R., Ruser G., Mäcke H., Briner U., Tolcsvai L., Weckbecker G., Bruns C. Synthesis, radiolabelling, and evaluation of DTPA/octreotide conjugates for radiotherapy. J. Labelled Compd. Radiopharm. 37:1995;499-501.
29. Smith-Jones P.M., Stolz B., Bruns C., Albert R., Reist H.W., Friedrich R., Mäcke H.R. Gallium-67/gallium-68-[DFO]-octreotide - A potential radiopharmaceutical for PET imaging of somatostatin receptor-positive tumors Synthesis and radiolabeling in vitro and preliminary in vivo studies . J. Nucl. Med. 35:1994;317-325.
30. 3-octreotide in tumor bearing rodents. J. Nucl. Med. 38:1997;18P.
31. 86Y-DTPA-octreotide . Nucl. Med. Biol. 1997:1997;275-286.
32. Xu M., Cutler P.D., Luk W.K. An adaptive local threshold segmented attenuation correction methods for whole-body PET imaging. IEEE Trans. Nucl. Sci. 43:1996;331-336.
33. 188Re-RC-160, a directly-radiolabeled somatostatin analogue. Int. J. Cancer. 65:1996;214-220.